Vote Scores
Filings read through

Bio-Techne Corporation: how funds voted at the meeting of 30 Oct 2025

Ticker
TECH
Meeting
Season
year to 30 June 2026
Filers reporting
803
Ballot items
4

803 filers on Form N-PX reported votes at the Bio-Techne Corporation meeting of 30 Oct 2025. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    9 nominees. 96.1% of the reported votes are for. 34 filers withheld from or voted against at least one nominee.

    5,194 vote records from 254 filers. 2 of the 254 filers that marked the item voted against management.

    • Positions of 52 fund families
    • For 52
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    1,262 vote records from 800 filers. 353 of the 777 filers that marked the item voted against management. 23 filers gave no management mark.

    • Positions of 54 fund families
    • For 29
    • Against 25
    • Against management 25
  3. Item 3: Audit-related items (auditor ratification)

    670 vote records from 254 filers. 2 of the 254 filers that marked the item voted against management.

    • Positions of 52 fund families
    • For 52
  4. Item 4: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    481 vote records from 206 filers. 1 of the 206 filers that marked the item voted against management.

    • Positions of 49 fund families
    • For 49

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Bio-Techne Corporation, meeting of 30 Oct 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinAgainst, against managementFor
AllspringAgainst, against managementFor
American BeaconAgainst, against managementFor
American CenturyAgainst, against managementFor
BairdAgainst, against managementFor
BlackRock and iSharesForFor
BNY MellonAgainst, against managementFor
Brighthouse FundsForFor
Capital Group and American FundsForFor
Charles SchwabForFor
Columbia ThreadneedleForFor
DimensionalAgainst, against managementFor
DWSAgainst, against managementFor
EquitableAgainst, against managementFor
Federated HermesForFor
FidelityForFor
First TrustAgainst, against managementFor
Franklin TempletonAgainst, against managementFor
Global XForFor
Goldman SachsAgainst, against managementFor
Guggenheim and RydexAgainst, against managementFor
Hartford FundsForFor
InvescoAgainst, against managementFor
J.P. MorganForFor
Jackson National fundsForFor
Janus HendersonAgainst, against managementNo report
John Hancock and ManulifeAgainst, against managementFor
Lincoln FinancialForFor
Lord AbbettAgainst, against managementFor
Macquarie and Delaware FundsAgainst, against managementFor
MassMutualForFor
MFSForFor
Morgan Stanley, Eaton Vance and CalvertForFor
NationwideForFor
Natixis and Loomis SaylesForNo report
Neuberger BermanForFor
Northern Trust and FlexSharesForFor
Nuveen and TIAAForFor
Pacific Life fundsForFor
PGIM and PrudentialAgainst, against managementFor
PrincipalAgainst, against managementFor
ProShares and ProFundsAgainst, against managementFor
Russell InvestmentsForFor
SEIForFor
State Street and SPDRForFor
T. Rowe PriceForFor
ThriventAgainst, against managementFor
TransamericaForFor
VanEckForFor
VanguardForFor
Victory CapitalAgainst, against managementFor
VirtusAgainst, against managementFor
VoyaAgainst, against managementFor
WisdomTreeForFor

Questions

How many filers reported votes at the Bio-Techne Corporation meeting?
803 Form N-PX filers reported votes at the meeting of 30 Oct 2025. On say-on-pay, 353 of 777 filers that marked the item voted against management (45.4%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Bio-Techne Corporation reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Bio-Techne Corporation with a meeting date within three days of 30 Oct 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .